TBK1 and melanoma: After the amlexanox treatment, we detected a significant downregulation of LC3B-II and an upregulation of p62, indicating that the inhibition of TBK1 and/or IKKε counteracts the induction of autophagy and might thereby inhibit the proliferation of melanoma cells (Figure 4).